Skip Navigation

Cardiovascular Research 2003 58(3):671-678; doi:10.1016/S0008-6363(03)00322-5
© 2003 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Schmidt, A.
Right arrow Articles by Buddecke, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schmidt, A.
Right arrow Articles by Buddecke, E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2003, European Society of Cardiology

Exogenous nitric oxide causes overexpression of TGF-β1 and overproduction of extracellular matrix in human coronary smooth muscle cells

Annette Schmidta,*, Sven Geigenmuellera, Wolfgang Voelkera, Petra Seilera and Eckhart Buddeckeb

aInstitute of Arteriosclerosis Research, University of Muenster, Department of Molecular Cardiology, Domagkstrasse 3, D-48149 Muenster, Germany
bInstitute of Physiological Chemistry and Pathobiochemistry, University of Muenster, Muenster, Germany

annschm{at}uni-muenster.de

* Corresponding author. Tel.: +49-251-835-8626; fax: +49-251-835-8628.

Objective: Nitric oxide (NO) is a major signalling molecule in the vascular system enhancing vascular smooth muscle cell relaxation and vasodilation. NO donors are the most frequently and repeatedly used drugs for relief from angina pectoris. Methods: We investigated the effects of the synthetic NO donor DETA/NO on cultured human coronary smooth muscle cells. Results: Cells exposed to 100 µM DETA/NO for 48–72 h were channeled into a cell cycle-arrested hypertrophic growth status associated with overexpression of TGF-β1 on both the protein and mRNA levels. Increased TGF-β1 transcription and translation were associated with enhanced synthesis of extracellular matrix components including the collagen types I and III as shown by immunocytochemistry and enhanced incorporation of [3H]proline. Higher incorporation of [35S]sulfate into chondroitin/dermatan sulfate and heparan sulfate containing proteoglycans was observed in DETA/NO treated cells than in controls. The ratio of chondroitin/dermatan sulfate to heparan sulfate did not change significantly. Conclusions: Our results suggest a dual function of the overexpressed TGF-β1. Overexpressed TGF-β1 could stabilize the fibrous cap overlaying atherosclerotic plaques due to the accumulation of extracellular matrix components. However, the findings could also support a proatherogenic role of TGF-β1 resulting from the overexpression of LDL-binding proteoglycans.

KEYWORDS Nitric oxide; Gene expression; Smooth muscle; Connective tissue; Growth factor


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
EndocrinologyHome page
R. Schreckenberg, S. Wenzel, R. M. da Costa Rebelo, A. Rothig, R. Meyer, and K.-D. Schluter
Cell-Specific Effects of Nitric Oxide Deficiency on Parathyroid Hormone-Related Peptide (PTHrP) Responsiveness and PTH1 Receptor Expression in Cardiovascular Cells
Endocrinology, August 1, 2009; 150(8): 3735 - 3741.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. F.H. Lai, D. W. Courtman, and D. J. Stewart
NO to Small Mothers Against Decapentaplegic (Smad)
Circ. Res., November 25, 2005; 97(11): 1087 - 1089.
[Full Text] [PDF]


Home page
Circ. Res.Home page
M. Saura, C. Zaragoza, B. Herranz, M. Griera, L. Diez-Marques, D. Rodriguez-Puyol, and M. Rodriguez-Puyol
Nitric Oxide Regulates Transforming Growth Factor-{beta} Signaling in Endothelial Cells
Circ. Res., November 25, 2005; 97(11): 1115 - 1123.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.